Percutaneous Coronary Intervention

The Healio team is providing live coverage of the American Heart Association's Scientific Sessions in Philadelphia.

SAN FRANCISCO — The first-time application of a triple-drug, site-specific antithrombotic therapy on a stent platform was safe and effective for managing thrombotic and bleeding risk after PCI, data presented at TCT 2023 show.

SAN FRANCISCO — In a new meta-analysis, researchers reaffirmed safety and efficacy of ticagrelor monotherapy to reduce major bleeding after 3-month dual antiplatelet therapy among patients who underwent PCI for ACS.

SAN FRANCISCO — Among patients treated for drug-eluting in-stent restenosis, the revascularization rate at 10 years was high, according to the results of a post hoc analysis of the ISAR-DESIRE 3 trial presented at TCT 2023.

Transradial access is now the predominant access site for complex, high-risk PCI procedures and is associated with significantly lower risk for mortality, major bleeding and other adverse events compared with transfemoral access, data show.

Boston Scientific announced the FDA clearance of its next-generation IVUS and fractional flow reserve system designed improve guidance during PCI.

Implementation of a CT angiography-derived fractional flow reserve program on a national level was associated with reduced risk for mortality and fewer downstream CV tests at 2 years, according to the results of the FISH&CHIPS study.

New data presented at the European Society of Cardiology Congress indicate that use of intravascular imaging during PCI improves clinical outcomes, but the issue of adoption is complicated.

Immediate PCI of nonculprit lesions during index hospitalization for STEMI was shown to be noninferior with fewer adverse events vs. a staged strategy addressing the nonculprit lesions after successful primary PCI, a speaker reported.

The use of intravascular imaging — OCT or IVUS — during PCI appears to reduce complications and produce overall better clinical outcomes than using angiography guidance, according to three studies and a meta-analysis.